16.1 Differential Diagnosis of Vaginitis & Bacterial Vaginosis
Key Takeaways
- Bacterial vaginosis is an ecological dysbiosis from loss of hydrogen-peroxide-producing Lactobacillus, not infection by a single pathogen.
- Amsel criteria require 3 of 4: thin homogeneous discharge, vaginal pH above 4.5, a positive whiff-amine test, and clue cells on more than 20 percent of squamous cells.
- The Nugent score on Gram stain is the laboratory gold standard for bacterial vaginosis.
- Vaginal pH is normal in candidiasis, typically 4.0 to 4.5, but elevated above 4.5 in both bacterial vaginosis and trichomoniasis.
- Trichomoniasis is caused by a flagellated protozoan and is sexually transmitted, which makes partner treatment necessary, unlike bacterial vaginosis.
Vaginal discharge, vulvar pruritus, and pelvic pain are among the most common presenting complaints in ambulatory women's health. The normal vaginal ecosystem is a finely balanced microenvironment dominated by hydrogen peroxide-producing Lactobacillus species (L. crispatus, L. jensenii), which ferment glycogen into lactic acid to maintain an acidic protective vaginal pH of 3.8 to 4.5. Disruptions in this protective barrier permit polymicrobial dysbiosis, fungal proliferation, or colonization by virulent sexually transmitted pathogens. For the certified nurse-midwife, precise clinical microscopy, rapid diagnostic triaging, strict adherence to CDC treatment guidelines, and timely intervention for pelvic inflammatory disease are essential to prevent long-term sequelae such as tubal factor infertility, ectopic pregnancy, and preterm birth.
Differential Diagnosis of Common Vaginitis
Vaginitis is clinically classified into three predominant conditions: Bacterial Vaginosis (BV), Vulvovaginal Candidiasis (VVC), and Trichomoniasis. Diagnostic accuracy relies on the synthesis of clinical presentation, nitrazine pH testing, the 10% potassium hydroxide (KOH) amine whiff test, and direct point-of-care microscopy.
| Diagnostic Parameter | Bacterial Vaginosis (BV) | Vulvovaginal Candidiasis (VVC) | Trichomoniasis |
|---|---|---|---|
| Etiologic Agent | Polymicrobial dysbiosis: Loss of protective Lactobacillus; overgrowth of Gardnerella vaginalis, Atopobium vaginae, Prevotella, Mobiluncus, and anaerobes | Candida albicans (85%–90%); Candida glabrata (10%–15%); opportunistic fungal overgrowth | Trichomonas vaginalis: flagellated, anaerobic parasitic protozoan; sexually transmitted |
| Typical Discharge | Thin, homogeneous, off-white or gray; smoothly coats vaginal walls; non-adherent | Thick, white, curd-like, flocculent "cottage cheese"; adheres tenaciously to vaginal mucosa | Copious, thin-to-purulent, frothy yellow-green; foul or musty odor |
| Primary Symptoms | Pronounced "fishy" odor (worse after intercourse or menses); mild vulvar discomfort; absent inflammation | Intense vulvar pruritus, burning, excoriations, dyspareunia, external "splash" dysuria | Marked vulvar pruritus, burning, severe dyspareunia, postcoital spotting, dysuria |
| Vaginal pH | Elevated (>4.5), typically 5.0 to 5.5 | Normal acidic (4.0 to 4.5) | Elevated (>4.5), typically 5.0 to 7.0 |
| 10% KOH Whiff Test | Positive (Sharp, pungent fishy amine odor released upon adding KOH) | Negative (No amine odor) | Frequently Positive or variable |
| Saline Wet Mount | Clue cells present (>20%); stippled borders obscured by coccobacilli; absent WBCs | Intact squamous cells; abundant white blood cells (WBCs); blastoconidia and pseudohyphae | Motile, flagellated trichomonads with jerky, twitching motility; abundant WBCs |
| 10% KOH Wet Mount | Dissolves epithelial cells; clue cells cleared | Budding yeast (blastospores) & branching pseudohyphae visualized clearly | Protozoa lyse; non-diagnostic |
| Physical Exam | Normal vulva and vaginal mucosa; lack of erythema or edema | Intense erythema and edema of vulva/labia; satellite pustules; mucosal fissures | Severe vaginal erythema; Colpitis macularis ("strawberry cervix") with punctate hemorrhages |
| CDC First-Line Treatment | Metronidazole 500 mg PO BID x 7 days OR Metronidazole gel 0.75% 5 g PV daily x 5 days OR Clindamycin 2% cream 5 g PV qhs x 7 days | Fluconazole 150 mg PO single dose (Uncomplicated non-pregnant) OR Topical azoles (Clotrimazole 1%–2% cream PV x 7 days) | Metronidazole 500 mg PO BID x 7 days (Preferred for women) OR Tinidazole 2 g PO single dose |
| Partner Management | Partner treatment NOT recommended (does not prevent recurrence) | Partner treatment NOT recommended (not an STI) | MANDATORY simultaneous treatment of all sexual partners; Expedited Partner Therapy (EPT) |
| Obstetric Risks | Strongly linked to Preterm Labor (PTL), PPROM, chorioamnionitis, and postpartum endometritis | Discomfort; oral fluconazole contraindicated in pregnancy (use 7-day topical azoles only) | Premature rupture of membranes, preterm birth, low birth weight infant |
Bacterial Vaginosis: Pathogenesis & Diagnostic Criteria
Bacterial Vaginosis (BV) is the most prevalent cause of abnormal vaginal discharge in reproductive-age individuals. It is not an infection of a single pathogen, but rather an ecological dysbiosis characterized by the catastrophic collapse of hydrogen peroxide-producing Lactobacillus species. In their absence, facultative and obligate anaerobic bacteria proliferate up to 1,000-fold. These anaerobes produce decarboxylase enzymes that convert amino acids into volatile amines (putrescine, cadaverine, trimethylamine), which volatilize at high pH and generate the characteristic fishy malodor.
Amsel Clinical Criteria
Diagnosis requires the presence of at least 3 of the following 4 criteria:
- Thin, homogeneous, white-to-gray discharge smoothly coating the vaginal walls.
- Vaginal pH >4.5 (measured using narrow-range nitrazine paper touched to lateral vaginal wall).
- Positive Whiff-Amine Test: Release of a distinct fishy amine odor immediately following the addition of one drop of 10% potassium hydroxide (KOH) to vaginal secretions.
- Clue Cells on Saline Wet Mount: Greater than 20% of squamous vaginal epithelial cells must be clue cells (squamous cells whose borders are completely obscured and stippled by masses of adherent coccobacilli, giving a "ground-glass" appearance, with loss of sharp cellular margins).
Nugent Score (Laboratory Gold Standard)
A standardized Gram stain scoring system (0 to 10) evaluating the proportion of large Gram-positive rods (Lactobacillus morphotypes), small Gram-variable rods (Gardnerella and Bacteroides morphotypes), and curved Gram-variable rods (Mobiluncus). A score of 7 to 10 is definitively diagnostic of BV (0–3 is normal; 4–6 is intermediate).
CDC Recommended Treatment & Clinical Nuances
- First-Line Regimens:
- Metronidazole 500 mg PO BID for 7 days (highest efficacy for eradicating systemic and vaginal reservoirs).
- Metronidazole 0.75% vaginal gel, one full applicator (5 g) intravaginally once daily at bedtime for 5 days.
- Clindamycin 2% vaginal cream, one full applicator (5 g) intravaginally at bedtime for 7 days.
- Patient Counseling: Advise patients taking oral metronidazole to avoid alcohol consumption during therapy and for at least 24 hours afterward to prevent disulfiram-like ethanol reactions (nausea, vomiting, abdominal cramping, flushing, tachycardia). Clindamycin cream is oil-based and can weaken latex condoms and diaphragms for up to 72 hours post-treatment.
- Pregnancy Considerations: Symptomatic pregnant individuals should be treated with either oral Metronidazole 500 mg BID for 7 days or oral Clindamycin 300 mg BID for 7 days. Treatment relieves symptoms and eliminates bacterial reservoirs associated with preterm birth, chorioamnionitis, and postpartum endometritis.
A 28-year-old G1P0 at 14 weeks gestation presents to the prenatal clinic complaining of severe, unremitting vulvar pruritus, external burning on urination, and a thick white vaginal discharge. Physical examination reveals intense erythema and edema of the labia minora and vulva with excoriations, and thick curd-like white discharge adhering to the vaginal sidewalls. Vaginal pH is 4.2. Saline wet mount shows white blood cells and epithelial cells, and a 10% KOH preparation reveals budding yeast and pseudohyphae. The whiff test is negative. Which of the following treatments is the most appropriate and safe for this patient?